Selected article for: "clinical course and MERS cov"

Author: Coperchini, Francesca; Chiovato, Luca; Croce, Laura; Magri, Flavia; Rotondi, Mario
Title: The Cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
  • Cord-id: ex9nh1yi
  • Document date: 2020_5_11
  • ID: ex9nh1yi
    Snippet: In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similar
    Document: In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called “cytokine storm” an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.

    Search related documents:
    Co phrase search for related documents
    • acid aspiration and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acid aspiration and acute phase: 1
    • acid ribonucleic and acute phase: 1
    • acid ribonucleic and acute respiratory tract infection: 1
    • acid ribonucleic and adaptive immune response: 1
    • acid ribonucleic and adaptive innate: 1, 2
    • activate immune cell and adaptive immune response: 1, 2
    • activate immune cell and adaptive innate: 1, 2, 3
    • activate immune cell and adaptive innate immune system: 1
    • activator protein and acute lung injury: 1, 2, 3, 4
    • activator protein and adaptive innate: 1
    • active passive and acute lung injury: 1
    • active passive and adaptive immune response: 1
    • active passive and adaptive innate: 1, 2
    • active passive and adaptive innate immune system: 1
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immune system: 1, 2, 3
    • acute inflammation and adaptive immune response: 1, 2, 3, 4